This is a guest post from BiotechBlog reader Viren Konde. Do you have a response to Viren’s post? If so, […]
India, Intellectual Property and Biotechnology Industry Read Post »
With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that
Biologic data exclusivity: The arguments for and against it Read Post »
In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products
In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products
Guest content from John Avellanet, managing director and principal of Cerulean Associates: Intellectual Property Theft on the Rise By John